• About Us
  • Contact Us
  • Submit News Release
Wednesday, March 22, 2023
No Result
View All Result
submit news
Oman News Club
  • BUSINESS
  • ENERGY
  • FINANCE
  • HEALTHCARE
  • LIFESTYLE
  • REAL ESTATE
  • TECH
  • TRAVEL
  • MIDDLE EAST
  • PRESS RELEASES
  • BUSINESS
  • ENERGY
  • FINANCE
  • HEALTHCARE
  • LIFESTYLE
  • REAL ESTATE
  • TECH
  • TRAVEL
  • MIDDLE EAST
  • PRESS RELEASES
No Result
View All Result
Oman News Club
Submit PR
Home PRESS RELEASES

Antidiabetic Biosimilars Market Demand, Growth Analysis Forecast 2022-2028

by Newsroom Editor
October 20, 2022
Share on FacebookShare on Twitter


(EMAILWIRE.COM, October 20, 2022 ) According to Precision Business Insights (PBI) latest report, the global antidiabetic biosimilars market is expected to reach huge growth during the forecast period 2022-28. In diabetic individuals, anti-diabetics assist manage blood glucose levels. Biguanides, thiazolidinediones, DPP-IV inhibitors, -glucosidase inhibitors, sulfonylureas, insulin, and GLP-1 receptor agonists like exenatide are a few examples of antidiabetics. An FDA-approved biological product known as a reference product serves as the basis for the approval of a biosimilar product, which is a biological product. Manufacturers of biosimilars must produce data from laboratory and clinical testing to show that the biosimilar they have developed offers patients the same therapeutic value as the reference medicine.

View Complete Report: https://precisionbusinessinsights.com/market-reports/anti-diabetic-biosimilars-market/

The Antidiabetic Biosimilars Market Growth Factors

A favorable environment for the market’s expansion is being created by the rising prevalence of diabetes, the complexity of substitute diabetic therapies, and government subsidies for the introduction of affordable therapies. Around 59.8 million people in Europe had diabetes in 2015, in accordance with the International Diabetes Federation (IDF). Due to a rise in antidiabetic product-related research activities and encouraging government financing, the market for an antidiabetic biosimilar is anticipated to be significant in the near future in the Asia Pacific region. Given the rising rate of diabetes in North America, this region is anticipated to be a lucrative market for antidiabetic biosimilars in the near future.

The Antidiabetic Biosimilars Market Segmentation

The Global Antidiabetic Biosimilars Market on the basis of Drug Class, the market is categorized into Insulin, Biguanides, Sulfonyl Ureas, Thiazolidinediones, Di Peptidyl Peptidase (DPP)-IV Inhibitors, α-glucosidase Inhibitors, GLP-1 Agonists, SGLT-2 Inhibitors, Others. On the basis of Disease Type, the market is classified into Type-I Diabetes, Type-II Diabetes. On the basis of the Distribution Channel, the market is divided into Hospital Pharmacies, Retail Pharmacies, and Online Pharmacies.

The Antidiabetic Biosimilars Market Trends

• A favorable environment for market expansion is being created by factors such as rising diabetes incidence, the complexity of alternative diabetic medicines, and government subsidies for the launch of affordable therapies.

• The prevalence of lifestyle diseases like obesity is rising, which raises the chance of developing diabetes and, in turn, fuels the demand antidiabetic biosimilars.

Request Sample Of The Report https://precisionbusinessinsights.com/request-sample?product_id=19747

The Antidiabetic Biosimilars Market Regional Analysis

The APAC Antidiabetic biosimilars market was dominated by India in 2021 with a share of 81.2%. One of the nation’s top priorities is the development of the biopharmaceutical sector as the Indian government works to achieve self-sufficiency. For example, the Indian government is investing billions in the study and development of biotechnology.

The major players operating in the Antidiabetic Biosimilars Market are Biocon (India), Merck Sharp & Dohme Corporation (U.S.), Boehringer Ingelheim GmbH (Germany), Eli Lilly & Co. (U.S.), Sanofi-aventis U.S. LLC (U.S.), Samsung Bioepis (Samsung BioLogics) (South Korea), Mylan N.V. (U.S.), Wockhardt (India)

Regional Reports:

Asia Pacific Anti diabetic Biosimilars Market By Drug Class (Insulin, Biguanides, Sulfonyl Ureas, Thiazolidinediones, Di Peptidyl Peptidase (DPP)-IV Inhibitors, α-glucosidase Inhibitos, GLP-1 Agonists, SGLT-2 Inhibitors, Others), By Disease Type (Type-I Diabetes, Type-II Diabetes), By Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Online Pharmacies)and Geography

https://precisionbusinessinsights.com/market-reports/asia-pacific-anti-diabetic-biosimilars-market/

North America Anti diabetic Biosimilars Market: By Drug Class (Insulin, Biguanides, Sulfonyl Ureas, Thiazolidinediones, Di Peptidyl Peptidase (DPP)-IV Inhibitors, α-glucosidase Inhibitos, GLP-1 Agonists, SGLT-2 Inhibitors, Others), By Disease Type (Type-I Diabetes, Type-II Diabetes), By Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Online Pharmacies)and Geography

https://precisionbusinessinsights.com/market-reports/north-america-anti-diabetic-biosimilars-market/

Europe Anti diabetic Biosimilars Market By Drug Class (Insulin, Biguanides, Sulfonyl Ureas, Thiazolidinediones, Di Peptidyl Peptidase (DPP)-IV Inhibitors, α-glucosidase Inhibitos, GLP-1 Agonists, SGLT-2 Inhibitors, Others), By Disease Type (Type-I Diabetes, Type-II Diabetes), By Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Online Pharmacies) and Geography

https://precisionbusinessinsights.com/market-reports/europe-anti-diabetic-biosimilars-market/

Latin America Anti Diabetic Biosimilars Market By Drug Class (Insulin, Biguanides, Sulfonyl Ureas, Thiazolidinediones, Di Peptidyl Peptidase (DPP)-IV Inhibitors, α-glucosidase Inhibitos, GLP-1 Agonists, SGLT-2 Inhibitors, Others), By Disease Type (Type-I Diabetes, Type-II Diabetes), By Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Online Pharmacies)and Geography

https://precisionbusinessinsights.com/market-reports/latin-america-anti-diabetic-biosimilars-market/

About Precision Business Insights:

We are a market research company that strives to provide the highest quality market research insights. Our diverse market research experts are enthusiastic about market research and therefore produce high-quality research reports. We have over 500 clients with whom we have a good business partnership and capacity to provide in-depth research analysis for more than 30 countries. In addition to deliver more than 150 custom solutions, we already have accounts with the top five medical device manufacturers. Precision Business Insights offers a variety of cost-effective and customized research services to meet research requirements. We are a leading research service provider because of our extensive database built by our experts and the services we provide.

Contact:

Mr. Satya

Precision Business Insights | Toll Free: +1 866 598 1553

Email: sales@precisionbusinessinsights.com

Kemp House, 152 – 160 City Road, London EC1V 2NX

Web: https://precisionbusinessinsights.com/ | D U N S® Number: 852781747



Source link

Previous Post

The Secret Source of Planning and Cutting Fancy Color Diamonds

Next Post

Marine Coatings Market is Growing Exponentially in Order to Gain More Demand by 2022

Next Post
Marine Coatings Market is Growing Exponentially in Order to Gain More Demand by 2022

Marine Coatings Market is Growing Exponentially in Order to Gain More Demand by 2022

No Result
View All Result

Categories

  • BUSINESS (23)
  • ENERGY (35)
  • FINANCE (35)
  • HEALTHCARE (35)
  • LIFESTYLE (35)
  • MIDDLE EAST (82)
  • PRESS RELEASES (673)
  • REAL ESTATE (35)
  • TECH (20)
  • TRAVEL (20)

Recent.

BioMap and MBZUAI team up on joint biocomputing lab to promote sustainable development and human health in the Middle East

Correction: BioMap and MBZUAI team up on joint biocomputing lab to promote sustainable development and human health in the Middle East

March 20, 2023

New project worth more than OMR8mn to be distinctive investment … – Times of Oman

March 20, 2023
Electrolyzers Market worth $23.6 Billion by 2028

Electrolyzers Market worth $23.6 Billion by 2028

March 20, 2023

Subscribe to our Newsletter

    Share Us

    Categories

    Categories
    • BUSINESS
    • ENERGY
    • FINANCE
    • HEALTHCARE
    • LIFESTYLE
    • MIDDLE EAST
    • PRESS RELEASES
    • REAL ESTATE
    • TECH
    • TRAVEL

    Recent News

    Recent Posts
    • Correction: BioMap and MBZUAI team up on joint biocomputing lab to promote sustainable development and human health in the Middle East
    • New project worth more than OMR8mn to be distinctive investment … – Times of Oman
    • Electrolyzers Market worth $23.6 Billion by 2028
    • Air Motor Market expected to hit USD 1.08 Bn by 2029 during the forecast period

    About Us

    OmanNews.Club™ reports, publishes and aggregates business, Tech and lifestyle news on Oman the Middle East and the North Africa (MENA). 

    We provide press release distribution to media outlets in Oman, Arab countries and the (MENA) regions. Submit a press release or contact us today.

    Oman News is part of GroupWeb Media Network. @ 2023 GroupWeb Media LLC

    About Us / Contact Us / Submit News Release

    No Result
    View All Result
    • About Us
    • Cart
    • Checkout
    • Contact Us
    • Home
    • My account
    • Shop
    • Submit News Release
    • Test page

    Oman News is part of GroupWeb Media Network. @ 2023 GroupWeb Media LLC